Neurology® Podcast

Dr. Justin Abbatemarco talks with Dr. Maarten Titulaer about long-term cognitive and functional outcomes in patients with anti-NMDAR encephalitis and their implications for rehabilitation.

Read the related article in Neurology.

Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Dr. Elias Sotirchos about the underlying etiologies of myelitis in patients with rheumatologic disease.

Read the related article in Neurology: Neuroimmunology & Neuroinflammation.

Disclosures can be found at Neurology.org.

Dr. Gregg Day talks with Dr. Kathryn T. Hall about the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments. 

Disclosures can be found at Neurology.org.

Dr. Justin Abbatemarco talks with Dr. Ahmad Nehme about the complexities of diagnosing and differentiating between cerebral amyloid angiopathy-related inflammation and biopsy-positive primary angiitis of the central nervous system.

Read the related article in Neurology.

Disclosures can be found at Neurology.org.

In the concluding segment of this two-part series, Dr. Justin Abbatemarco talks with Dr. Jennifer L. Orthmann-Murphy about genetic leukodystrophies and the increasing recognition of these disorders in adult neurology, the importance of genetic testing, and the evolving treatment landscape. 

Read the related articles in Neurology and CHS Perspectives. 

Disclosures can be found at Neurology.org.

In the first part of this two-part series, Dr. Justin Abbatemarco talks with Dr. Jennifer L. Orthmann-Murphy about a practical approach to genetic leukodystrophies, focusing on the importance of genetic testing, identifying red flags in patients, and navigating the complexities of hereditary spastic paraplegia.

Read the related articles in Neurology and CHS Perspectives.

Disclosures can be found at Neurology.org.

The November 2024 replay features four episodes dedicated to brain health. It kicks off with an interview with Dr. Nicoline Schiess, who discusses the World Health Organization (WHO) Brain Health Unit. Next, Dr. Katrin Seeher delves into the global burden of neurological conditions and the WHO’s strategies to enhance care and awareness. The third segment features Dr. Natalia Rost who introduces and highlights the American Academy of Neurology’s (AAN) groundbreaking brain health initiative. The episode wraps up with Dr. Rost again, who returns to give an update and emphasize the urgency of addressing brain health amidst public health challenges.

Podcast Links:

WHO Brain Health Unit

Global Burden of Neurologic Conditions

Brain Health Initiative with Dr. Natalia Rost

Update on Brain Health with Dr. Natalia Rost

Article Links:

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

The Brain Health Imperative in the 21st Century—A Call to Action

AAN Brain Health Initiative

Disclosures can be found at Neurology.org.

Dr. Justin Abbatemarco talks with Drs. Marius Ringelstein and Ilya Ayzenberg about the effectiveness and safety of Eculizumab in routine clinical care.

Read the related article in Neurology.

Disclosures can be found at Neurology.org.

Dr. Tesha Monteith talks with Drs. Messoud Ashina and Andrea Cipriani about all licensed drug interventions as oral monotherapy for the acute treatment of migraine episodes in adults.

Read the related article in the BMJ.

Disclosures can be found at Neurology.org.

Dr. Greg Cooper talks with Dr. Clifford R. Jack Jr about objective criteria for diagnosis and staging Alzheimer disease, highlighting recent advancements in biomarkers to bridge the gap between research and clinical practice.

Read the related article in Alzheimer's Association.

Disclosures can be found at Neurology.org.